# Evaluation of the Safety and Immunogenicity of a Live Attenuated Human Metapneumovirus Vaccine

> **NCT01255410** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 60 (actual)

## Conditions studied

- Metapneumovirus

## Interventions

- **BIOLOGICAL:** 10^6 PFU rHMPV-Pa vaccine
- **BIOLOGICAL:** 10^5 PFU rHMPV-Pa vaccine
- **BIOLOGICAL:** Placebo Vaccine

## Key facts

- **NCT ID:** NCT01255410
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2014-10
- **Final completion:** 2015-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01255410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01255410, "Evaluation of the Safety and Immunogenicity of a Live Attenuated Human Metapneumovirus Vaccine". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01255410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*